The GLP is committed to full transparency. Download and review our 2019 Annual Report

Marijuana compound CBD could help people fight opioid addiction

| | May 29, 2019

This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

A new study out [May 21] is the latest to suggest that cannabis—or at least a key ingredient of it—might help people struggling with addiction. It found that people with opioid use disorder experienced less symptoms of craving when given cannabidiol, or CBD, over a placebo.

[Researchers] recruited 42 men and women who had been living with opioid use disorder, specifically heroin, but were currently not using the drug. Half were randomly given pills containing CBD (actually just Epidiolex), in two dosages, while the rest took a placebo. Then, over the course of a week, the volunteers had to watch three-minute long videos either containing nothing but neutral images, like nature sounds, or videos featuring drug paraphernalia like syringes or bags of powder meant to look like heroin.

Related article:  Viewpoint: Our efforts to learn more about cannabis benefits, risks are hampered by federal research barriers

The test subjects were given CBD for three days, and they were tested for post-video craving and anxiety symptoms immediately after they took a pill, a day after a CBD session, and a week after the last session. Across these scenarios, the researchers found, people on CBD reported less craving and anxiety on average than the placebo group.

Read full, original post: CBD Might Help People Struggling With Opioid Addiction, Small Trial Shows

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend